Search

Your search keyword '"Classical swine fever"' showing total 6,755 results

Search Constraints

Start Over You searched for: "Classical swine fever" Remove constraint "Classical swine fever" Topic classical swine fever Remove constraint Topic: classical swine fever Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
6,755 results on '"Classical swine fever"'

Search Results

1. Geographic risk of classical swine fever in non-free regions in Brazil.

2. Stability of closed and needle-punctured vials of Porvac® subunit vaccine against classical swine fever subjected to thermal stress.

3. Porvac ® subunit vaccine induces neutralizing antibodies against all three main classical swine fever virus genotypes.

4. Efficacy of GPE - strain live attenuated vaccine and CP7_E2alf strain recombinant live vaccine (marker vaccine) against Japanese epidemic classical swine fever virus isolated in 2019 and DIVA discrimination ability of the marker vaccine.

5. Recent decline in hepatitis E virus prevalence among wild boars in Japan: Probably due to countermeasures implemented in response to outbreaks of classical swine fever virus infection.

6. Immunogenicity of a classical swine fever bait vaccine (Flc-LOM- BE rns ) in hybrid-wild boars.

7. Development of classical swine fever virus E2-protein based indirect ELISA for detection of antibodies against the virus in pigs.

8. Pathogenicity of genotype 2.1 classical swine fever virus isolated from Japan in 2019 in pigs.

9. Development of an indirect ELISA for the immunoprotection evaluation of E2 antibodies against classical swine fever virus.

10. CRISPR/Cas9-mediated knockout of STAT1 in porcine-derived cell lines to elucidate the role of STAT1 in autophagy following classical swine fever virus infection.

11. Classical swine fever: Unveiling the complexity through a multifaceted approach.

12. Assessment of the Safety Profile of Chimeric Marker Vaccine against Classical Swine Fever: Reversion to Virulence Study.

13. Safety and DIVA Capability of Novel Live Attenuated Classical Swine Fever Marker Vaccine Candidates in Pregnant Sows.

14. Novel approach for detecting classical swine fever virus from swabs of wild boar cut tails using nested real-time PCR.

15. Enhancing classical swine fever virus identification: the advantages of Field-LAMP testing.

16. Elucidation of novel SNPs affecting immune response to classical swine fever vaccination in pigs using immunogenomics approach.

17. Application of machine learning with large-scale data for an effective vaccination against classical swine fever for wild boar in Japan.

18. Oral Fluids for the Early Detection of Classical Swine Fever in Commercial Level Pig Pens.

19. Development of a new loop-mediated isothermal amplification test for the sensitive, rapid, and economic detection of different genotypes of Classical swine fever virus.

20. Classical swine fever virus non-structural protein 5B hijacks host METTL14-mediated m6A modification to counteract host antiviral immune response.

21. N pro of classical swine fever virus enhances HMGB1 acetylation and its degradation by lysosomes to evade from HMGB1-mediated antiviral immunity.

22. Analysis of effective spatial range of oral vaccination against classical swine fever for wild boar.

23. Molecular and Pathological Characterization of Classical Swine Fever Virus Genotype 2 Strains Responsible for the 2013-2018 Outbreak in Colombia.

24. Evolutionary-Related High- and Low-Virulent Classical Swine Fever Virus Isolates Reveal Viral Determinants of Virulence.

25. Classical swine fever virus NS5A protein activates autophagy via the PP2A-DAPK3-Beclin 1 axis.

26. Host cell factors involved in classical swine fever virus entry.

27. Rice-produced classical swine fever virus glycoprotein E2 with herringbone-dimer design to enhance immune responses.

28. The regulation of cell homeostasis and antiviral innate immunity by autophagy during classical swine fever virus infection.

29. Efficacy of an orally administered classical swine fever live marker vaccine (Flc-LOM-BE rns strain) in pigs.

30. N-terminal domain of classical swine fever virus N pro induces proteasomal degradation of specificity protein 1 with reduced HDAC1 expression to evade from innate immune responses.

31. Attachment, Entry, and Intracellular Trafficking of Classical Swine Fever Virus.

32. Identification of two novel T cell epitopes on the E2 protein of classical swine fever virus C-strain.

33. Development and application of classical swine fever virus monoclonal antibodies derived from single B cells.

34. Role of OGDH in Atophagy-IRF3-IFN-β pathway during classical swine fever virus infection.

35. Assessing mammal fence crossing and local fence management in relation to classical swine fever spread in Japan.

36. Optimized protocol for double vaccine immunization against classical swine fever and porcine reproductive and respiratory syndrome.

37. Generation and Efficacy of Two Chimeric Viruses Derived from GPE - Vaccine Strain as Classical Swine Fever Vaccine Candidates.

38. High expression of the classical swine fever virus (CSFV) envelope protein E2 by a single amino acid mutation and its embedded in the pseudorabies virus (PRV) vector for immunization.

39. Intracellular Vimentin Regulates the Formation of Classical Swine Fever Virus Replication Complex through Interaction with NS5A Protein.

40. Exosomes secreted by CSFV-infected cells evade neutralizing antibody to activate innate immune responses and establish productive infection in recipient cells.

41. A Genetically Engineered Bivalent Vaccine Coexpressing a Molecular Adjuvant against Classical Swine Fever and Porcine Epidemic Diarrhea.

42. Classical Swine Fever Virus Structural Glycoprotein E2 Interacts with Host Protein ACADM during the Virus Infectious Cycle.

43. Evaluation of an alternative method for determination of Protective Dose 50 of Classical swine fever vaccines.

44. Development of Porcine Monoclonal Antibodies with In Vitro Neutralizing Activity against Classical Swine Fever Virus from C-Strain E2-Specific Single B Cells.

45. Construction and efficacy of a new live chimeric C-strain vaccine with DIVA characteristics against classical swine fever.

46. 25-hydroxycholesterol inhibits classical swine fever virus entry into porcine alveolar macrophages by depleting plasma membrane cholesterol.

47. Establishment of guinea pig kidney cell lines with potential application in the production of a classical swine fever live GPE - vaccine.

48. Recombinant pseudorabies virus (PRV) expressing stabilized E2 of classical swine fever virus (CSFV) protects against both PRV and CSFV.

49. A Novel Blocking Enzyme-Linked Immunosorbent Assay Based on a Biotinylated Nanobody for the Rapid and Sensitive Clinical Detection of Classical Swine Fever Virus Antibodies.

50. Circulation of classical swine fever virus (CSFV) strains of bovine origin in China and India.

Catalog

Books, media, physical & digital resources